送件食藥署 聯亞正式提出EUA申請
財經中心／許珮絨報導聯亞生技日前公布國產疫苗二期臨床試驗期中分析報告，聯亞藥（6562）今（30）代母公司聯亞生技公告，正式向台灣衛福部食藥署申請新冠肺炎疫苗UB-612之緊急使用
Lin mark this message contains true information
｜originally written by Lin
聯亞藥指出，母公司聯亞生技開發公司向台灣衛福部食藥署申請新冠肺炎疫苗UB-612之EUA，後續將協助同集團的Vaxxinity公司於印度執行1.1萬名受試者之第三期臨床試驗。
References
https://tw.news.yahoo.com/新-聯亞向食藥署正式提出eua申請-112049932.htmlhttps://tw.news.yahoo.com/%E6%96%B0-%E8%81%AF%E4%BA%9E%E5%90%91%E9%A3%9F%E8%97%A5%E7%BD%B2%E6%AD%A3%E5%BC%8F%E6%8F%90%E5%87%BAeua%E7%94%B3%E8%AB%8B-112049932.html
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.